{"id":"usual-cefepime-infusion","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Infusion site reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Cefepime works by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, resulting in the disruption of the bacterial cell wall synthesis and ultimately leading to bacterial cell death. This mechanism of action is specific to Gram-positive and Gram-negative bacteria.","oneSentence":"Cefepime is a fourth-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:53:43.042Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Nosocomial pneumonia"},{"name":"Complicated urinary tract infections"},{"name":"Complicated skin and skin structure infections"}]},"trialDetails":[{"nctId":"NCT02568800","phase":"PHASE3","title":"Prolonged Infusion Cefepime and Nosocomial Infections","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2015-10","conditions":"Urinary Tract Infection, Respiratory Tract Infection","enrollment":134}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Regular Cefepime Infusion"],"phase":"phase_3","status":"active","brandName":"Usual Cefepime Infusion","genericName":"Usual Cefepime Infusion","companyName":"Hospital de Clinicas de Porto Alegre","companyId":"hospital-de-clinicas-de-porto-alegre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cefepime is a small molecule antibiotic used to treat urinary tract infections and respiratory tract infections. It is administered through infusion, with both prolonged and usual infusion methods being studied in clinical trials.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}